Muscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancer

The prognosis of patients with Borrmann type IV gastric cancer (Type IV) is extremely poor. Thus, there is an urgent need to elucidate the molecular mechanisms underlying the oncogenesis of Type IV and to identify new therapeutic targets. Although previous studies using whole‐exome and whole‐genome...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Yasumoto, Makiko, Sakamoto, Etsuko, Ogasawara, Sachiko, Isobe, Taro, Kizaki, Junya, Sumi, Akiko, Kusano, Hironori, Akiba, Jun, Torimura, Takuji, Akagi, Yoshito, Itadani, Hiraku, Kobayashi, Tsutomu, Hasako, Shinichi, Kumazaki, Masafumi, Mizuarai, Shinji, Oie, Shinji, Yano, Hirohisa
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Cancer Biology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5269692/
https://ncbi.nlm.nih.gov/pubmed/27891760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.959
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars